ERLOTINIB ZENTIVA 150 mg, comprimé pelliculé — plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930187548 -
CIP7
3018754 -
CIS
61581890
What the source publishes
- Holder
- ZENTIVA FRANCE
- Active ingredients
- CHLORHYDRATE D'ERLOTINIB, ERLOTINIB
- Form
- comprimé pelliculé
- Package
- plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2019-07-31
- Prescription
- Prescription or restricted
Names this record is found by
- ERLOTINIB ZENTIVA 150 mg, comprimé pelliculé — plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés
- ERLOTINIB ZENTIVA 150 mg, comprimé pelliculé
- CHLORHYDRATE D'ERLOTINIB
- ERLOTINIB
Complete source data
{
"cis": "61581890",
"cip7": "3018754",
"form": "comprimé pelliculé",
"name": "ERLOTINIB ZENTIVA 150 mg, comprimé pelliculé — plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés",
"cip13": "3400930187548",
"holder": "ZENTIVA FRANCE",
"routes": [
"orale"
],
"holders": [
"ZENTIVA FRANCE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "851.04",
"authorisedOn": "2019-07-31",
"compositions": [
{
"name": "CHLORHYDRATE D'ERLOTINIB",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "27387",
"dosageReference": null,
"pharmaceuticalElement": "comprimé"
},
{
"name": "ERLOTINIB",
"nature": "FT",
"strength": "150 mg",
"linkageNumber": "1",
"substanceCode": "56421",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "850.02",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ERLOTINIB ZENTIVA 150 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100 %"
],
"marketingDeclaredOn": "2020-03-23",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE D'ERLOTINIB",
"ERLOTINIB"
],
"authorisationProcedure": "Procédure de reconnaissance mutuelle",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930187548"